πŸ‡ΊπŸ‡Έ FDA
Patent

US 11760799

Leptin antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 11760799 (Leptin antibodies) held by The Board of Regents of the University of Texas System expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61P, A61P3/04, A61P3/10